Alan Burnett



Prosiectau fel Prif Ymchwiliwr
null null 1 o 5 null null

Strengthen and develop scientific and technological excellence in research therapy of leukaemia - Cyllidwr:Commission of the European Communities (01.01.2004 - 28.02.2011)
Acute Myeoild Leukaemia Trial (AML 15) Trial Grant - Cyllidwr:Medical Research Council (01.07.2002 - 31.12.2009)
Cardiff Experimental Cancer Medicine Centre - Cyllidwr:Cancer Research UK (01.04.2007 - 31.03.2012)
Nexus monitoring - Cyllidwr:Genzyme Therapeutics Limited (01.11.2011 - 31.01.2013)


Prosiectau fel Cyd-Ymchwiliwr
null null 2 o 2 null null

Cancer Genetics Biomedical Research Unit - Cyllidwr:Welsh Government (HCRW) (31.03.2011 - 31.05.2015)
Investigation of the role of RAL dysregulation in myeloid leukaemia - Cyllidwr:Leukaemia Research Fund (01.11.2008 - 31.10.2011)
CD200: A putative target of AML - Cyllidwr:Leukaemia Research Fund (01.12.2008 - 30.11.2011)
Role of OGG1 in the pathogenesis of acute myeloid leukaemia - Cyllidwr:Welsh Government (01.04.2009 - 30.09.2011)

Diweddarwyd y tro diwethaf ar 2020-03-05 am 04:07